Clinical Trials · NCT00309985
Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Enrollment
- 790
- Start date
- Sep 2006
- Locations
- 343 sites, United States
- Primary endpoint
- Overall Survival